trending Market Intelligence /marketintelligence/en/news-insights/trending/xdojehchnbff0pahyvg6va2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Pieris Pharmaceuticals closes common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Pieris Pharmaceuticals closes common stock offering

Pieris Pharmaceuticals Inc. closed its underwritten public offering of 6,325,000 common shares at $8 apiece with gross proceeds of about $50.6 million.

The shares sold include the full exercise of the underwriters' option to buy up to an additional 825,000 common shares.

The Boston-based drugmaker plans to use the proceeds for working capital and general corporate purposes, including advancing the development of its drug candidates.

Jefferies, Cowen and Evercore ISI acted as joint book-running managers for the offering.